Tumor affinity of 99mTc-labeled radiopharmaceuticals, 99mTc-Sn-urokinase and 99mTc-Sn-mannitol

Biolgic distribution of 99mTc-labeled fibrinolytic agent, urokinase, and 99mTc-labeled mannitol, which was obtained as a side-product in the preparation of 99mTc(Sn)-urokinase, have been studied in Ehrlich's tumor-bearing mice to get a promising indicator for the positive delineation of malignant tumor. The preparation of 99mTc-labeled radiopharmaceuticals, 99mTc-UK and 99mTc-Man, was made by the reduction with stannous chloride and labeling efficiency was examined by Sephadex G-25M gel chromatography and by silica gel plate thin layer chromatography. Labeling yield of 99mTc-UK by Sephadex G25M in 0.9% NaCl eluant was 13% and that of 99mTc-Man by TLC in 85% methanol solvent was over 95%. A higher uptake to the implanted solid tumor tissue in mice was found in 99mTc-Man than in 99mTc-UK, of which the excellent tumor accumulation was expected from the positive delineation of malignant tumor with 131I-fibrinogen, 131I-fibrinogen antibody and 125I-plasmin. The poor result in 99mTc-UK, however, may be attributed to the poor fibrinolytic activity of Ehrlich's tumor. In biologic distribution of 99mTc-UK was found high concentration for liver kidney and stomach. In the other hand, a higher tumor tissue uptake, a fast blood disappearance and a low concentration for different organs were found in biologic distribution of 99mTc-Man. Therefore, 99mTc-Man may be assumed as a more preferable 99mTc-labeled tumor localizing radiopharmaceuticals, to which it would be needed as absolute biologic characteristics that 99mTc-labeled compounds possess a high tumor uptake as well as a fast blood disappearance with a low uptake for different organs. However, the possible delineation with 99mTc-labeled fibrinolytic agents, including urokinase and streptokinase, may be promised for malignant tumors in human-subject, which generally have a higher activity in fibrinogenesis than in fibrinolysis.     

In vivo and in vitro 99mTc-protein bound of renal agents: 99mTc-prylidinomethyltetracycline (99mTc-Sn-Pmt) and 99mTc-Sn-Gluco-ene-diolate (99mTc-Gluco)

Protein binding affects tissue distribution, plasma clearance and uptake of renal radiopharmaceuticals. The ^99mTc bound to plasma protein after incubation ^99mTc-Gluco-ene-diolate (^99mTc-Sn-Gluco) agent or ^99mTc-prylidinomethyl-tetracycline (^99mTc-Sn-PMT) agent with plasma protein. It was observed that the protein bound to ^99mTc is lesser extent with (^99mTc-Sn-Gluco) agent than with the ^99mTc-PMT agent. ^99mTc-Sn-PMT is excreted more rapidly than ^99mTc-Sn-Gluco. On the other hand the percentage binding to protein seems to depend on the origin of the protein and or the type of protein (human or animal). However lower human protein binding or higher protein binding were observed with ^99mTc-Sn-Gluco or with ^99mTc-Sn-PMT, respectively compared with the binding to rat protein. The unbroken down of the chemical form of the origin of these two agents and the highest of ^99mTc-Sn-Gluco remained as origin in urine indicate that ^99mTc-Sn-Gluco are more stable than ^99mTc-Sn-PMT.Concerning the type of protein binding to ^99mTc-Sn-PMT or to ^99mTc-Sn-Gluco, it was observed that Human Plasma Protein is greater binding than Human serum protein or than IgG.     

Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (2) 99mTc-Sn-diphosphonate (99mTc-EHDP), 99mTc-Sn-dimercaptosuccinic acid (99mTc-DMSA), and 99mTc-Sn-diethyl stilbestrol diphosphate (99mTc-DSDP)]

The authors have examined the tumor affinity of various 99mTc-labelled radiopharmaceuticals to Ehrlich's tumor for the purpose of delineating positively human malignant neoplasm. This paper includes biologic distributions of 99mTc-Sn-diphosphonate (99mTc-EHDP), 99mTc-Sn-dimercaptosuccinic acid (99mTc-DMSA) and 99mTc-Sn-diethyl stilbestrol diphosphate (99mTc-DSDP, 99mTc-Honvan) as the second report on the tumor affinity to the Ehrlich-bearing mice. (a) Tumor concentration of 99mTc-EHDP was lowest and the positive delineation of implanted tumor with 99mTc-EHDP was poorest in sequential images, though the active accumulation to some soft tissue maglinant neoplasms, the breast cancer and the thyroid cancer, has been reported. (b) Tumor concentration and tumor to blood ratio of 99mTc-DMSA were not so high on the contrary of our expectation that 197Hg-DMSA may show the high tumor concentration and the high tumor to blood ratio like 197Hg chlormerodrin as same renal scanning radiopharmaceuticals. (c) Tumor concentration of 99mTc-DSDP was highest. Tumor to blood concentration ratio, however, was lower than that of the above mentioned radiopharmaceuticals but tumor to liver ratio and/or tumor to lung ratio was over 1.0 at the earlier time. Biologic distribution of 99mTc-DSDP was similar to that of 32P labeled DSDP and then it is presumed that 99mTc is labeled at phosphate ester of DSDP which is dephospholytated immediately by phospholylase in vivo following the intravenous injection. Therefore, it may be assumed that the accumulation mechanism of 99mTc-DSDP to Ehrlich's tumor is related to the phospholylase activity in neoplasms but is not known precisely.     

Desorption of99Mo from spent99Mo/99mTc generator

A simple method for desorption and purification of⁹⁹Mo from spent⁹⁹Mo/^99mTc generators is described. The alumina column was washed successively with 0.9% saline water, 35% H₂O₂, and then the⁹⁹Mo was eluted with 2M NH₄OH. Ammonia and residual H₂O₂ were removed by heating the eluate. Finally,⁹⁹Mo solution was passed through a 0.2 m membrane filter to remove precipitated aluminium hydroxide.     

Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (1) 99mTc-pertechnetate, 99mTc-human serum albumin, and 99mTc-trasylol]

This paper describes biologic distributions, sequential images and macroautoradiograms of 99mTcO4 (pertechnetate), 99mTc-Sn-HSA (human serum albumin) and 99mTc-Sn-TSL (trasylol) in tumor-bearing mice as the first report on tumor affinity of 99mTc-labeled radiopharmaceutical. (1) Maximum tumor concentration (% administered dose/g of tissue weight) of 99mTcO4, 99mTc-HSA and 99mTc-TSL in Ehrlich's tumor-bearing mice resulted in 2.03+/-0.57 at 1 hr, 4.02+/-0.19 at 3 hr and 1.97+/-0.31 at 1 hr respectively. (2) However, tumor to blood concentration ratio of 99mTc-HSA was lowest among them. (3) The corrected tumor accumulation (% 100g dose/g of tissue wt.=% dose/% body weight) of 99mTc-TSL to Ehrlich's tumor in mouse was not different from that of Yoshida's sarcoma in rat, on the contrary to our expectation that the tumor concentration of 99mTc-TSL in them might be different due to differency of the tissue fibrinolytic activity between the respective tumors. (4) Sequential images of the implanted tumor in mouse was best positively delineated with 99mTc-HSA. (5) Macroautoradiograms of Ehrlich's tumor with 99mTcO4, 99mTc-HSA and 99mTc-TSL demonstrated the following findings: all of them were not only accumulated markedly into the tumor cells which were shown as basophilic tissue with H?matoxylin-Eosin staining but also accumulated around the tumor tissue and on the interstitial tissue which were stained as eosinophilic tissue with the above same staining.     

Technetium-99 in “instant”99mTc-pertechnetate

The⁹⁹Tc-content in^99mTc-pertechnetate separated from⁹⁹Mo by distillation or extraction has been studied with a plastic scintillation detector. The identification of the measured activity was achieved by beta-spectrometry, chemical separation and half-life studies. The frequency distribution of the⁹⁹Tc/^99mTc-ratios in the different samples was observed to be log-normal. The most likely activity ratio was 0.4·10⁻⁶, the maximum value being 5·10⁻⁶. The specific activity of “instant” pertechnetate is approximately a factor of 60 lower than that normally recorded in pertechnetate derived from daily eluted column generators. The low specific activity of “instant” pertechnetate is primarily explained by the long time between separation and usage and secondly by the low yield of Tc in the distillation and extraction processes. In several of the “instant” pertechnetate solutions the carrier concentration exceeded the reductive capacity of the stannous ions in “kits” with small amounts of Sn(II) in usable form.     

Clinical comparison of 99mTc-diethylenetriaminepentaacetic acid-human serum albumin (99mTc-HSA-D) and 99mTc-human serum albumin (99mTc-HSA) for cardiac blood pool imaging

99mTc-HSA-D has been developed as a new blood pool scanning agent. Clinical comparison of 99mTc-HSA-D and 99mTc-HSA was made in 16 cases. The activity concentration of 99mTc in blood was measured during 2 hours after the injection in five cases. 99mTc-HSA-D showed higher concentration compared to 99mTc-HSA with the passage of time. Quantitative analysis of contrast between left ventricle and septum was performed on end diastolic frames of gated images 10 minutes after the injection. There was no obvious difference between 99mTc-HSA-D and 99mTc-HSA. The subjective comparison of detectability of lesions between the two agents was performed on three directional gated images. 99mTc-HSA-D was superior to 99mTc-HSA, because the images of the latter deteriorated with the passage of time. On anterior view images 1 hour after the injection, left ventricle/lung and abdominal aorta/background count ratios were greater for 99mTc-HSA-D in many cases. There was no obvious difference in liver/background and kidney/background count ratios between the two agents. Urinary excretion of 99mTc was considerably lesser for 99mTc-HSA-D. The results indicated that 99mTc-HSA-D was superior to 99mTc-HSA for cardiac blood pool imaging.     

Biodistribution of the bone imaging agents99mTc-DHPE and99mTc-MDP in rats

The self life of the freeze-dried formulation kits utilized for the preparation of the new bone imaging radiopharmaceutical^99mTc-1,2-dihydroxy-1,2-bis/dihydroxyphosphinyl/ethane /^99mTc-DHPE/ has been investigated as well as the toxicity of the DHPE. In a biodistribution investigation of^99mTc-DHPE in rats, in comparison to^99mTc-methylenediphosphanate /^99mTc-MDP/,^99mTc-DHPE exhibited a certain extent higher skeleton uptake, a higher blood clearance rate, a very low concentration in other organs, a satisfactory biological stability and excretion primarily through the kidneys. These properties demonstrate that^99mTc-DHPE is a new promising skeleton imaging radio-pharmaceutical.     

Pharmaceutical grade sodium [99mTc] pertechnetate from low specific activity 99Mo using an automated 99Mo/99mTc-TCM-autosolex generator

Performance study of a computer controlled automated closed cyclic module for the separation and recovery of ^99mTc from low specific activity (n, γ) ⁹⁹Mo using methyl ethyl ketone (MEK) solvent extraction technique named ⁹⁹Mo/^99mTc-TCM-AUTOSOLEX (Technetium automated solvent extraction) Generator is described. The entire system is automated and controlled by a user-friendly PC based graphical user interface that actually supervises process via an embedded system based electronic controller. The average yield of separation of ^99mTc was above 85 % and ⁹⁹Mo breakthrough in ^99mTc pertechnetate was <0.002 %. The sodium pertechnetate obtained was a clear solution having pH 6–7, Radiochemical (RC). Purity >99 %, MEK content <0.1 % (v/v), Al and Mo content <10 µg/ml. R. C. Purity of ^99mTc-radiopharmaceuticals studied was not less than 96 %. Bio-Quality control studies confirm that sodium pertechnetate obtained was sterile and pyrogen free. Imaging studies in animals and humans with limited radiopharmaceuticals show that the quality of ^99mTc-pertechenate obtained in the present module was good enough to do clinical study.     

A99Mo-99mTc generator based on the use of zirconium molybdophosphate-99Mo gel

A modified⁹⁹Mo–^99mTc gel generator is described. The present generator uses an insoluble zirconium molybdophosphate (ZrMP) gel tagged with⁹⁹Mo. Molybdenum-99 is chemically combined in the gel structure and cannot be eluted from the matrix. The presence of phosphate increases the chemical stability of the gel and decreases the molybdenum breakthrough. The prepared gel is sufficiently porous to permit ready diffusion of^99mTcO ₄ ^– which can be cluted with saline in yields of up to 90%. The gel was found to contain 25.1% Mo, 21.9% Zr, and 0.7% P in a molar ratio of 1.09:1.0:0.09, respectively. The high molybdenum content of the gel allows the use of cheap, non-polluting (n, )⁹⁹Mo. The eluted^99mTc was of high purity and can be used for medical and pharmaceutical applications.     

Separation and purification of 99mTc from 99Mo produced by electron linear accelerator

The medical radionuclide ⁹⁹Mo was produced by the ¹⁰⁰Mo(γ,n) reaction using bremsstrahlung photons generated by an electron linear accelerator. The amount of ⁹⁹Mo produced was compared to that predicted by calculation using the particles and heavy ion transport code system. From the ⁹⁹Mo produced, highly pure ^99mTc was separated using the so-called technetium master milker, and the chemical yield of ^99mTc was 83–99 %. The installation of a new complex using this method and the electron linear accelerator with the preferable specification was suggested, and a possibility to supply the demand of ^99mTc was discussed and shown.

     

99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers

Nuclear medicine relies on two main imaging modalities: single photon emission computed tomography (SPECT) and positron emission tomography (PET). Radiopharmaceuticals (or radiotracers) are the blood stream of nuclear medicine for the diagnosis or therapy of diseases. Diagnostic radiotracers that are small molecules labelled with a gamma-emitter for SPECT or positron-emitter for PET provide a non-invasive method to assess the disease or disease states and monitor the therapeutic efficacy of a specific treatment regime. Over the past four decades, radiopharmaceutical research has been practising one-pot synthesis at the tracer level (10(-7)-10(-6) M). Many (99m)Tc radiotracers currently used in nuclear medicine are routinely prepared by following the basic principles of one-pot synthesis. Unlike traditional organic one-pot synthesis, which often involves the formation of multiple C-C and C-heteroatom bonds in a single step, the (99m)Tc-centered one-pot synthesis requires the formation of multiple coordination bonds between Tc and various donor atoms, such as N, O, S and P. This review will illustrate how the (99m)Tc-centered one-pot synthesis is utilized for routine preparations of different (99m)Tc radiotracers.     

Preparation of 99Mo/99mTc generator based on alumina 99Mo-molybdate (VI) gel

In this work alumina ⁹⁹Mo-molybdate (VI) gel is evaluated as a column matrix for use in the preparation of small chromatographic column type ^99mTc generator. Alumina molybdate (VI) gel is prepared by dissolving inactive MoO₃ with aluminum foil in 5 M NaOH solution containing ⁹⁹Mo radiotracer. After complete dissolution, 0.5 H₂O₂ was added to the reaction mixture solution and acidified to pH 5.5 with concentrated HNO₃. The formed AlMo precipitate was washed with NaNO₃ solution, dried at 50 °C for 24 h and then packed in the form of a chromatographic column for elution of the generated ^99mTc radionuclide with physiological saline solution (0.9 % NaCl). Greater than 86 % of the generated ^99mTc activity is immediately and reproducibly eluted with passing 10 mL of the saline solution through 2.0 g of alumina ⁹⁹Mo-molybdate column bed at a flow rate of about 1.0 mL/min. The high radiochemical ≥98.6 % TcO₄ ^?, radionuclidic ≥99.90 % ^99mTc and chemical purities of the eluates satisfy the specifications for use in nuclear medicine.     

Determination of technetium in99Mo/99m Tc-generators

The Tc budget in several ROTOP-generators was determined by neutron activation analysis (NAA) and UV-spectroscopy. The complete procedure included the preparation of the generator, elution cycle in 24 to 72 h intervals and evaporation of the eluates to dryness. The samples were aliquoted, irradiated in the reactor and analyzed via⁹⁹Tc(n, n')^99mTc⁹⁹Tc reaction as well as by UV-absorption due to pertechnetate. The most reliable method proved to be NAA including chemical separation from²⁴Na by ion exchange after the complete decay of³⁸Cl. The detection limit was 50 ppb (3 ng Tc), compared with the total amount of several 10^–5 g down to 10^–7 g Tc in the system and its fractions. The mass balance and the elution profiles obtained correspond very well to the theoretical values. The results permit further quantitative considerations on both elution kinetics and the generator system.     

A simple and sensitive separation technique of 99Mo and 99mTc from their equilibrium mixture

The present work describes a simple and inexpensive separation method of ⁹⁹Mo from the equilibrium mixture. The liquid–liquid extraction technique has been employed to separate ⁹⁹Mo and ^99mTc using triisooctylamine (TIOA). The ⁹⁹Mo and ^99mTc were quantitatively separated out in 2 M TIOA with tripled distilled water; ^99mTc was back extracted from TIOA organic phase to aqueous phase by 0.1 M DTPA. The species information or indirect speciation of molybdenum was also established by the extraction profile of the molybdenum.     

Preparation of99Mo,132Te isotopes and99mTc,132I generators

Adsorption and desorption of⁹⁵Zr−⁹⁵Nb,⁹⁹Mo,¹⁰³Ru,¹³²Te and²³⁹Np in a HCl-alumina system were studied in order to purify⁹⁹Mo and¹³²Te obtained by the cation-exchange separation of fission products and to prepare highly pure^99mTc and¹³²I generators.⁹⁹Mo and¹³²Te, of which radionuclidic purity was over 99.99% and 99.999%, respectively, could be obtained by passing the cation-exchange separated Mo and Te fractions through alumina columns, by washing with HCl and finally by eluting⁹⁹Mo with 1M NH₄OH and¹³²Te with 3M NaOH. In order to raise the recovery of⁹⁹Mo and¹³²Te from the alumina columns, they should be eluted as quickly as possible after the adsorption. The direct use of the alumina column containing⁹⁹Mo or¹³²Te as the generator allowed milking of^99mTc or¹³²I, of which radionuclidic purity was over 99.999%. Milking yields of^99mTc with 0.1M HCl and¹³²I with 0.01M NH₄OH were 77% and 90%, respectively. The latter value was much higher than that in usual performance of the generator.